相关实验视频
Updated: Jun 11, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.4K
在整个发育过程中,花生过敏原的表征和过敏性
Casey G Cohen1, Yael Levy2, Diana Toscano-Rivero1
1Department of Pediatrics and Division of Experimental Medicine, McGill University and The Research Institute of The McGill University Health Centre (RI-MUHC), Montreal, Canada.
Frontiers in allergy
|September 30, 2024
概括
未成熟的花生种子显示过敏性降低,为更安全的口服免疫疗法 (OIT) 和改善儿童花生过敏 (PA) 诊断提供了潜力. 这项研究分析了不同发育阶段的过敏原含量.
科学领域:
- 食物过敏研究 食物过敏研究
- 植物科学 植物科学
- 免疫学 免疫学 免疫学
背景情况:
- 儿童的花生过敏 (PA) 是一个重大的健康问题.
- 目前用于PA的诊断和口服免疫疗法 (OIT) 方法需要改进的生物材料.
- 花生种子的发育可能会影响过敏性和治疗疗效.
研究的目的:
- 在连续的花生种子发育阶段评估主要过敏原含量.
- 用特定的IgE结合和皮肤刺伤测试来监测过敏性变化.
- 探索未成熟种子的潜力,以改善PA诊断和OIT.
主要方法:
- 在五个发育阶段 (S1-S5) 收集花生种子.
- 样品使用RNA-Seq,ELISA和免疫组织化学分析.
- 用不同发育阶段的种子提取物对儿童进行了皮肤刺伤测试.
主要成果:
- 过敏原含量和IgE结合随着种子成熟而增加.
- 早期的发育阶段 (S1,S2) 显示过敏性降低,偏向于不太过敏的Ara h 2变种.
- 皮肤刺痛测试显示,与成熟提取物相比,对未成熟的种子提取物 (S1,S2) 的反应性明显较低.
结论:
- 未成熟的花生种子由于过敏原水平较低和蛋白质构成变化而表现出较低的过敏性.
- 这些发现表明,有可能开发更安全,更有效的诊断工具和国际劳工组织 (OIT) 对花生过敏的协议.
- 种子发育阶段显著影响花生过敏原含量和临床反应性.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Cross-reactivity
31.0K
Overview
31.0K
Development of Immunocompetence
293
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
293
Antibody Structure
59.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.6K
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Antigens Involved in Adaptive Immunity
468
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
468

